N@N

Anupam Rama Maintained (APLS) at Buy with Decreased Target to $79 on, Nov 15th, 2022

Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Decreased Target from $81 to $79 on, Nov 15th, 2022.

Anupam has made no other calls on APLS in the last 4 months.

There are 9 other peers that have a rating on APLS. Out of the 9 peers that are also analyzing APLS, 3 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Thursday, November 10th, 2022
• Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022
• Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022

These are the ratings of the 6 analyists that currently disagree with Anupam

---

• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $123 on, Tuesday, October 18th, 2022
• Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022
• Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
• Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
• Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022

Contributing Sources

---